Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity-Reference-Cited by-同舟云学术

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Published:2017-11-08 Issue:7680 Volume:551 Page:340-345
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Shalapour Shabnam,Lin Xue-Jia,Bastian Ingmar N.,Brain John,Burt Alastair D.,Aksenov Alexander A.,Vrbanac Alison F.,Li Weihua,Perkins Andres,Matsutani Takaji,Zhong Zhenyu,Dhar Debanjan,Navas-Molina Jose A.,Xu Jun,Loomba Rohit,Downes Michael,Yu Ruth T.,Evans Ronald M.,Dorrestein Pieter C.,Knight Rob,Benner Christopher,Anstee Quentin M.,Karin Michael

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature24302.pdf

Reference76 articles.

1. Sharma, P., Wagner, K., Wolchok, J. D. & Allison, J. P. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat. Rev. Cancer 11, 805–812 (2011)

2. Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015)

3. Mittal, D., Gubin, M. M., Schreiber, R. D. & Smyth, M. J. New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape. Curr. Opin. Immunol. 27, 16–25 (2014)

4. Corthay, A. Does the immune system naturally protect against cancer? Front. Immunol. 5, 197 (2014)

5. Singal, A. G. & El-Serag, H. B. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin. Gastroenterol. Hepatol. 13, 2140–2151 (2015)

Cited by 421 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment;Biomedicine & Pharmacotherapy;2024-10

2. B-cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma;World Journal of Gastroenterology;2024-09-14

3. Targeted therapies in hepatocellular carcinoma: past, present, and future;Frontiers in Oncology;2024-08-29

4. Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy;2024-08-16

5. Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes;Cell;2024-08